{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:39:11Z","timestamp":1781534351686,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s42770-023-00966-8","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T11:02:49Z","timestamp":1681383769000},"page":"859-871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Seroprevalence of SARS-CoV-2 in hospital workers in the southern region of Minas Gerais state in Brazil: An analysis of the pre-vaccine period"],"prefix":"10.1007","volume":"54","author":[{"given":"Duillio Alves","family":"Caixeta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Araujo Vieira","family":"do Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio Guimar\u00e3es","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denismar Alves","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Felipe Leomil","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4920-072X","authenticated-orcid":false,"given":"Luiz Cosme Cotta","family":"Malaquias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"issue":"4","key":"966_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.00028-20","volume":"33","author":"K Dhama","year":"2020","unstructured":"Dhama K, Khan S, Tiwari R et al (2020) Coronavirus disease 2019\u2013COVID-19. Clin Microbiol Rev 33(4):1\u201348. https:\/\/doi.org\/10.1128\/CMR.00028-20","journal-title":"Clin Microbiol Rev"},{"key":"966_CR2","unstructured":"WHO. Coronavirus Disease 2019 (COVID-19) Situation Report \u2013 51;\u00a02020. Accessed June 13, 2022. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10"},{"key":"966_CR3","unstructured":"WHO. COVID-19 Weekly Epidemiological Update - 27 April 2022; 2022. https:\/\/www.who.int\/publications\/m\/item\/covid-19-weekly-epidemiological-update"},{"key":"966_CR4","unstructured":"Brasil. Covid-19: situa\u00e7\u00e3o epidemiol\u00f3gica do Brasil nesta quarta-feira (27) \u2014 Portugu\u00eas (Brasil). Minist\u00e9rio da Sa\u00fade. Published April 27, 2022. Accessed May 4, 2022. https:\/\/www.gov.br\/saude\/pt-br\/coronavirus\/informes-diarios-covid-19\/covid-19-situacao-epidemiologica-do-brasil-nesta-quarta-feira-27"},{"key":"966_CR5","unstructured":"Minas Gerais. Boletim Epidemiol\u00f3gico de 27 de Abril de 2022; 2022. Accessed May 4, 2022. https:\/\/coronavirus.saude.mg.gov.br\/images\/2022\/04\/Boletim_Completo_27.04.2022.pdf"},{"key":"966_CR6","doi-asserted-by":"publisher","unstructured":"Chan JF-W, Kok K-H, Zhu Z et al (2020) Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9(1):221. https:\/\/doi.org\/10.1080\/22221751.2020.1719902","DOI":"10.1080\/22221751.2020.1719902"},{"issue":"2","key":"966_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/J.CELL.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181(2):271. https:\/\/doi.org\/10.1016\/J.CELL.2020.02.052","journal-title":"Cell"},{"issue":"4","key":"966_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v12040372","volume":"12","author":"Y Jin","year":"2020","unstructured":"Jin Y, Yang H, Ji W et al (2020) Virology, epidemiology, pathogenesis, and control of covid-19. Viruses 12(4):1\u201317. https:\/\/doi.org\/10.3390\/v12040372","journal-title":"Viruses"},{"issue":"1","key":"966_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/J.JMII.2020.05.001","volume":"54","author":"Z Gao","year":"2021","unstructured":"Gao Z, Xu Y, Sun C et al (2021) A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect 54(1):12. https:\/\/doi.org\/10.1016\/J.JMII.2020.05.001","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"966_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells10020206","volume":"10","author":"R Chilamakuri","year":"2021","unstructured":"Chilamakuri R, Agarwal S (2021) COVID-19: Characteristics and Therapeutics. Cells 10(2):1\u201329. https:\/\/doi.org\/10.3390\/cells10020206","journal-title":"Cells"},{"key":"966_CR11","unstructured":"CDC. Symptoms of COVID-19. Centers for Disease Control and Prevention. Published February 22, 2021. Accessed September 15, 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html"},{"issue":"3","key":"966_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","volume":"15","author":"J Machhi","year":"2020","unstructured":"Machhi J, Herskovitz J, Senan AM et al (2020) The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. J Neuroimmune Pharmacol 15(3):359\u2013386. https:\/\/doi.org\/10.1007\/s11481-020-09944-5","journal-title":"J Neuroimmune Pharmacol"},{"key":"966_CR13","doi-asserted-by":"publisher","unstructured":"Ortiz-Prado E, Simba\u00f1a-Rivera K, G\u00f3mez- Barreno L et al (2020) Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis 98(1). https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115094","DOI":"10.1016\/j.diagmicrobio.2020.115094"},{"issue":"16","key":"966_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph17165648","volume":"17","author":"H Hozhabri","year":"2020","unstructured":"Hozhabri H, Sparascio FP, Sohrabi H et al (2020) The global emergency of novel coronavirus (SARS-CoV-2): An update of the current status and forecasting. Int J Environ Res Public Health 17(16):1\u201335. https:\/\/doi.org\/10.3390\/ijerph17165648","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"966_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.rbmo.2020.06.001","volume":"41","author":"A La Marca","year":"2020","unstructured":"La Marca A, Capuzzo M, Paglia T, Roli L, Trenti T, Nelson SM (2020) Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays. Reprod Biomed Online 41(3):483\u2013499. https:\/\/doi.org\/10.1016\/j.rbmo.2020.06.001","journal-title":"Reprod Biomed Online"},{"key":"966_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ijid.2020.10.008","volume":"101","author":"G Cota","year":"2020","unstructured":"Cota G, Freire ML, de Souza CS et al (2020) Diagnostic performance of commercially available COVID-19 serology tests in Brazil. Int J Infect Dis 101:382\u2013390. https:\/\/doi.org\/10.1016\/j.ijid.2020.10.008","journal-title":"Int J Infect Dis"},{"key":"966_CR17","doi-asserted-by":"publisher","unstructured":"Tozetto-Mendoza TR, Kanunfre KA, Vilas-Boas LS et al (2021) Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: Could an old assay be suitable for serodiagnosis of the new coronavirus? J Virol Methods:290. https:\/\/doi.org\/10.1016\/j.jviromet.2021.114064","DOI":"10.1016\/j.jviromet.2021.114064"},{"issue":"2","key":"966_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/jmv.26303","volume":"93","author":"M Tr\u00e9-Hardy","year":"2021","unstructured":"Tr\u00e9-Hardy M, Wilmet A, Beukinga I et al (2021) Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. J Med Virol 93(2):803\u2013811. https:\/\/doi.org\/10.1002\/jmv.26303","journal-title":"J Med Virol"},{"issue":"15","key":"966_CR19","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/cid\/ciaa310","volume":"71","author":"L Guo","year":"2020","unstructured":"Guo L, Ren L, Yang S et al (2020) Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis 71(15):778\u2013785. https:\/\/doi.org\/10.1093\/cid\/ciaa310","journal-title":"Clin Infect Dis"},{"issue":"6","key":"966_CR20","doi-asserted-by":"publisher","first-page":"450","DOI":"10.7326\/M20-2854","volume":"173","author":"MP Cheng","year":"2020","unstructured":"Cheng MP, Yansouni CP, Basta NE et al (2020) Serodiagnostics for Severe Acute Respiratory Syndrome-Related Coronavirus 2\u00a0: A Narrative Review. Ann Intern Med 173(6):450\u2013460. https:\/\/doi.org\/10.7326\/M20-2854","journal-title":"Ann Intern Med"},{"key":"966_CR21","unstructured":"Medronho RA, Bloch KV, Luiz RR, Werneck GL. Epidemiologia. Vol 1. 2nd ed. Atheneu; 2009. Accessed December 29, 2021. https:\/\/plataforma.bvirtual.com.br\/Leitor\/Publicacao\/185965\/pdf\/0?code=BEcNwqFq\/Ydl1o0pSmq7fJtGdBZR7BwBR3AGKKDxdFcaq\/8cu6goHTpFeH03tJvGslWhTxynhFne599qeQvfFQ=="},{"issue":"3","key":"966_CR22","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/J.JCVP.2022.100101","volume":"2","author":"FF Bagno","year":"2022","unstructured":"Bagno FF, S\u00e9rgio SAR, Figueiredo MM et al (2022) Development and validation of an enzyme-linked immunoassay kit for diagnosis and surveillance of COVID-19. Journal of Clinical Virology Plus 2(3):100101. https:\/\/doi.org\/10.1016\/J.JCVP.2022.100101","journal-title":"Journal of Clinical Virology Plus"},{"issue":"1","key":"966_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/AJE\/KWAA191","volume":"190","author":"SA G\u00f3mez-Ochoa","year":"2021","unstructured":"G\u00f3mez-Ochoa SA, Franco OH, Rojas LZ et al (2021) COVID-19 in Healthcare Workers: A Living Systematic Review and Meta-analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes. Am J Epidemiol 190(1):161\u2013175. https:\/\/doi.org\/10.1093\/AJE\/KWAA191","journal-title":"Am J Epidemiol"},{"key":"966_CR24","doi-asserted-by":"publisher","unstructured":"Dorrucci M, Minelli G, Boros S et al (2021) Excess Mortality in Italy During the COVID-19 Pandemic: Assessing the Differences Between the First and the Second Wave, Year 2020. Front Public Health:927. https:\/\/doi.org\/10.3389\/FPUBH.2021.669209\/FULL","DOI":"10.3389\/FPUBH.2021.669209\/FULL"},{"key":"966_CR25","unstructured":"Minas Gerais. Boletim Epidemiol\u00f3gico de 21 de janeiro de 2022. Secretaria de Estado de Sa\u00fade de Minas Gerais. Published January 21, 2022. Accessed January 22, 2022. https:\/\/coronavirus.saude.mg.gov.br\/images\/2022\/01\/COVID-19_-_BOLETIM20220121.pdf"},{"issue":"12","key":"966_CR26","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/S1473-3099(20)30589-2","volume":"20","author":"K Iversen","year":"2020","unstructured":"Iversen K, Bundgaard H, Hasselbalch RB et al (2020) Risk of COVID-19 in health-care workers in Denmark: an observational cohort study. Lancet Infect Dis 20(12):1401. https:\/\/doi.org\/10.1016\/S1473-3099(20)30589-2","journal-title":"Lancet Infect Dis"},{"key":"966_CR27","doi-asserted-by":"publisher","first-page":"113771","DOI":"10.1016\/J.IJHEH.2021.113771","volume":"235","author":"A Hildebrandt","year":"2021","unstructured":"Hildebrandt A, H\u00f6kelekli O, Uflacker L, Rudolf H, Gatermann SG (2021) COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study. Int J Hyg Environ Health 235:113771. https:\/\/doi.org\/10.1016\/J.IJHEH.2021.113771","journal-title":"Int J Hyg Environ Health"},{"key":"966_CR28","doi-asserted-by":"publisher","unstructured":"Faller E, Wyse A, Barry R et al (2021) Original research: Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland. BMJ Open 11(6). https:\/\/doi.org\/10.1136\/BMJOPEN-2021-051415","DOI":"10.1136\/BMJOPEN-2021-051415"},{"issue":"8","key":"966_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/OEMED-2020-107060","volume":"78","author":"L Milazzo","year":"2021","unstructured":"Milazzo L, Lai A, Pezzati L et al (2021) Original research: Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy. Occup Environ Med 78(8):541\u2013547. https:\/\/doi.org\/10.1136\/OEMED-2020-107060","journal-title":"Occup Environ Med"},{"key":"966_CR30","doi-asserted-by":"publisher","unstructured":"De Geyter D, Vancutsem E, Van Laere S et al (2021) SARS-CoV-2 seroprevalence among employees of a university hospital in Belgium during the 2020 COVID-19 outbreak (COVEMUZ-study). Epidemiol Infect 149. https:\/\/doi.org\/10.1017\/S0950268821001540","DOI":"10.1017\/S0950268821001540"},{"key":"966_CR31","unstructured":"Minas Gerais (2020) Boletim Epidemiol\u00f3gico: Cen\u00e1rio em Minas Gerais. Coronav\u00edrus. https:\/\/coronavirus.saude.mg.gov.br\/boletim2020. Accessed 29 Oct 2022."},{"key":"966_CR32","doi-asserted-by":"publisher","unstructured":"Prakash O, Solanki B, Sheth JK et al (2021) Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: A cross-sectional study. BMJ Open 11(1). https:\/\/doi.org\/10.1136\/bmjopen-2020-044101","DOI":"10.1136\/bmjopen-2020-044101"},{"key":"966_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/J.IJID.2020.10.036","volume":"102","author":"U Venugopal","year":"2021","unstructured":"Venugopal U, Jilani N, Rabah S et al (2021) SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic. Int J Infect Dis 102:63\u201369. https:\/\/doi.org\/10.1016\/J.IJID.2020.10.036","journal-title":"Int J Infect Dis"},{"key":"966_CR34","doi-asserted-by":"publisher","unstructured":"Bryan A, Tatem K, Diuguid-Gerber J et al (2021) Original research: Cross-sectional study evaluating the seroprevalence of SARS-CoV-2 antibodies among healthcare workers and factors associated with exposure during the first wave of the COVID-19 pandemic in New York. BMJ Open 11(11). https:\/\/doi.org\/10.1136\/BMJOPEN-2021-053158","DOI":"10.1136\/BMJOPEN-2021-053158"},{"issue":"5","key":"966_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.12788\/JHM.3627","volume":"16","author":"MU Purswani","year":"2021","unstructured":"Purswani MU, Bucciarelli J, Tiburcio J et al (2021) SARS-CoV-2 Seroprevalence Among Healthcare Workers by Job Function and Work Location in a New York Inner-City Hospital. J Hosp Med 16(5):282\u2013289. https:\/\/doi.org\/10.12788\/JHM.3627","journal-title":"J Hosp Med"},{"issue":"49","key":"966_CR36","doi-asserted-by":"publisher","first-page":"E1868","DOI":"10.1503\/CMAJ.202783\/TAB-RELATED-CONTENT","volume":"193","author":"N Brousseau","year":"2021","unstructured":"Brousseau N, Morin L, Ouakki M et al (2021) SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study. CMAJ. 193(49):E1868\u2013E1877. https:\/\/doi.org\/10.1503\/CMAJ.202783\/TAB-RELATED-CONTENT","journal-title":"CMAJ."},{"issue":"3","key":"966_CR37","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/J.JINF.2020.05.067","volume":"81","author":"Y Chen","year":"2020","unstructured":"Chen Y, Tong X, Wang J et al (2020) High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients. J Infect 81(3):420\u2013426. https:\/\/doi.org\/10.1016\/J.JINF.2020.05.067","journal-title":"J Infect"},{"issue":"11","key":"966_CR38","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.3390\/jcm9113752","volume":"9","author":"C Gillot","year":"2020","unstructured":"Gillot C, Douxfils J, Cadrobbi J et al (2020) An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens. J Clin Med 9(11):3752. https:\/\/doi.org\/10.3390\/jcm9113752","journal-title":"J Clin Med"},{"issue":"1","key":"966_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/IJPH.IJPH_1199_20","volume":"65","author":"O Prakash","year":"2021","unstructured":"Prakash O, Solanki B, Sheth JK, Kadam M, Vyas S (2021) Severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibody: Seroprevalence among contacts of COVID-19 cases. Indian J Public Health 65(1):5\u201310. https:\/\/doi.org\/10.4103\/IJPH.IJPH_1199_20","journal-title":"Indian J Public Health"},{"issue":"8","key":"966_CR40","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/J.CGH.2020.04.001","volume":"18","author":"F D\u2019Amico","year":"2020","unstructured":"D\u2019Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L (2020) Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management. Clin Gastroenterol Hepatol 18(8):1663. https:\/\/doi.org\/10.1016\/J.CGH.2020.04.001","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"966_CR41","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/LARY.29207","volume":"131","author":"M Mair","year":"2021","unstructured":"Mair M, Singhavi H, Pai A et al (2021) A Meta-Analysis of 67 Studies with Presenting Symptoms and Laboratory Tests of COVID-19 Patients. Laryngoscope 131(6):1254\u20131265. https:\/\/doi.org\/10.1002\/LARY.29207","journal-title":"Laryngoscope"},{"key":"966_CR42","doi-asserted-by":"publisher","unstructured":"Menezes AMB, Victora CG, Hartwig FP et al (2021) High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2. Sci Rep 11(1). https:\/\/doi.org\/10.1038\/S41598-021-92775-Y","DOI":"10.1038\/S41598-021-92775-Y"},{"issue":"13","key":"966_CR43","doi-asserted-by":"publisher","first-page":"12493","DOI":"10.18632\/AGING.103579","volume":"12","author":"X Fang","year":"2020","unstructured":"Fang X, Li S, Yu H et al (2020) Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging (Albany NY) 12(13):12493. https:\/\/doi.org\/10.18632\/AGING.103579","journal-title":"Aging (Albany NY)"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-00966-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-023-00966-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-00966-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T02:21:22Z","timestamp":1685672482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-023-00966-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1007\/s42770-023-00966-8","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"3 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the present study had no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}